(Corrects sourcing to ‘U.S. FDA’ from ‘Blueprint Medicines Corp’ in text)
Jan 9 (Reuters) - U.S. FDA:
* BLUEPRINT MEDICINES CORP RECEIVES FDA APPROVAL FOR AYVAKIT FOR TREATMENT OF RARE STOMACH CANCER - FDA WEBSITE Source text : (bit.ly/36FFxb1) Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.